TD Securities Boosts CRH Medical (CRH) Price Target to C$6.50
A number of other research firms have also issued reports on CRH. Royal Bank of Canada lifted their target price on CRH Medical from C$4.75 to C$5.00 and gave the company an outperform rating in a report on Friday, August 3rd. National Bank Financial lifted their target price on CRH Medical from C$5.00 to C$5.75 and gave the company an outperform rating in a report on Tuesday, August 21st.
Shares of TSE CRH opened at C$5.64 on Wednesday. CRH Medical has a twelve month low of C$1.86 and a twelve month high of C$5.75.
In related news, Director Ian A. Webb sold 7,500 shares of CRH Medical stock in a transaction on Tuesday, June 12th. The stock was sold at an average price of C$4.51, for a total value of C$33,825.00. Also, insider James Kreger sold 25,000 shares of CRH Medical stock in a transaction on Tuesday, August 7th. The shares were sold at an average price of C$4.47, for a total value of C$111,750.00.
About CRH Medical
CRH Medical Corporation provides various products and services to gastroenterologists for the treatment of gastrointestinal diseases in the United States, Canada, and internationally. It offers CRH O'Regan system, a single use, disposable, and hemorrhoid banding technology for treating various grades of hemorrhoid.
Receive News & Ratings for CRH Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CRH Medical and related companies with MarketBeat.com's FREE daily email newsletter.